A new drug for cancer

by Medindia Content Team on  September 7, 2001 at 2:12 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new drug for cancer
The Cancer Research Centre in the UK has been funding researchers who have pioneered a new drug, known as DMXAA. A drug that attacks a tumour's blood supply directly.

It represents a new approach to cancer, for it constricts the tiny blood vessels that feed a tumour, as well as activating the immune system to release chemicals such as interferon and tumor necrosis factor. This will open up a second line of attack, causing the blood vessels to leak and break down. Due to restriction of its blood supply, the tumour will start to wither and die.

Magnetic resonance imaging studies reveal that DMXAA reduces the blood flow to a tumour. The new drug will probably be used in combination with other anti-cancer drugs. DMXAA will strike the first blow, weakening the cancer by starving it of blood. Then, hopefully, other drugs will finish it off. DMXAA should enter full clinical trials towards the end of next year.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Cancer and Homeopathy Clinical Trials - Different Phases of the trial Signature Drug Toxicity Cancer Facts Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive